125 related articles for article (PubMed ID: 23954480)
1. Copper-64 radiolabelling of the C2A domain of synaptotagmin I using a functionalised bis(thiosemicarbazone): A pre- and post-labelling comparison.
Hueting R; Tavaré R; Dilworth JR; Mullen GE
J Inorg Biochem; 2013 Nov; 128():108-11. PubMed ID: 23954480
[TBL] [Abstract][Full Text] [Related]
2. Efficient site-specific radiolabeling of a modified C2A domain of synaptotagmin I with [99mTc(CO)3]+: a new radiopharmaceutical for imaging cell death.
Tavaré R; Torres Martin De Rosales R; Blower PJ; Mullen GE
Bioconjug Chem; 2009 Nov; 20(11):2071-81. PubMed ID: 19874007
[TBL] [Abstract][Full Text] [Related]
3. Mixed bis(thiosemicarbazone) ligands for the preparation of copper radiopharmaceuticals: synthesis and evaluation of tetradentate ligands containing two dissimilar thiosemicarbazone functions.
Lim JK; Mathias CJ; Green MA
J Med Chem; 1997 Jan; 40(1):132-6. PubMed ID: 9016338
[TBL] [Abstract][Full Text] [Related]
4. The C2A domain of synaptotagmin exhibits a high binding affinity for copper: implications in the formation of the multiprotein FGF release complex.
Rajalingam D; Kumar TK; Yu C
Biochemistry; 2005 Nov; 44(44):14431-42. PubMed ID: 16262243
[TBL] [Abstract][Full Text] [Related]
5. Photoactivatable bis(thiosemicarbazone) derivatives for copper-64 radiotracer synthesis.
Earley DF; Esteban Flores J; Guillou A; Holland JP
Dalton Trans; 2022 Mar; 51(13):5041-5052. PubMed ID: 35285835
[TBL] [Abstract][Full Text] [Related]
6. Species dependence of [64Cu]Cu-Bis(thiosemicarbazone) radiopharmaceutical binding to serum albumins.
Basken NE; Mathias CJ; Lipka AE; Green MA
Nucl Med Biol; 2008 Apr; 35(3):281-6. PubMed ID: 18355683
[TBL] [Abstract][Full Text] [Related]
7. A dual radiolabelling approach for tracking metal complexes: investigating the speciation of copper bis(thiosemicarbazonates) in vitro and in vivo.
Hueting R; Kersemans V; Tredwell M; Cornelissen B; Christlieb M; Gee AD; Passchier J; Smart SC; Gouverneur V; Muschel RJ; Dilworth JR
Metallomics; 2015 May; 7(5):795-804. PubMed ID: 25768310
[TBL] [Abstract][Full Text] [Related]
8. Cu(II) bis(thiosemicarbazone) radiopharmaceutical binding to serum albumin: further definition of species dependence and associated substituent effects.
Basken NE; Green MA
Nucl Med Biol; 2009 Jul; 36(5):495-504. PubMed ID: 19520290
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction.
Zhao M; Zhu X; Ji S; Zhou J; Ozker KS; Fang W; Molthen RC; Hellman RS
J Nucl Med; 2006 Aug; 47(8):1367-74. PubMed ID: 16883018
[TBL] [Abstract][Full Text] [Related]
10. Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia.
Bonnitcha PD; Bayly SR; Theobald MB; Betts HM; Lewis JS; Dilworth JR
J Inorg Biochem; 2010 Feb; 104(2):126-35. PubMed ID: 19932509
[TBL] [Abstract][Full Text] [Related]
11. On-cartridge preparation and evaluation of
Socan A; Petrik M; Kolenc Peitl P; Krošelj M; Rangger C; Novy Z; Svajger U; Gmeiner T; Decristoforo C
Nucl Med Biol; 2019 Apr; 71():23-31. PubMed ID: 31128475
[TBL] [Abstract][Full Text] [Related]
12. Phospholipid composition dependence of Ca2+-dependent phospholipid binding to the C2A domain of synaptotagmin IV.
Fukuda M; Kojima T; Mikoshiba K
J Biol Chem; 1996 Apr; 271(14):8430-4. PubMed ID: 8626542
[TBL] [Abstract][Full Text] [Related]
13. Localization of Rab3A-binding site on C2A domain of synaptotagmin I to reveal its regulatory mechanism.
Tang X; Xie C; Wang Y; Wang X
Int J Biol Macromol; 2017 Mar; 96():736-742. PubMed ID: 28057568
[TBL] [Abstract][Full Text] [Related]
14. Orthogonal 18F and 64Cu labelling of functionalised bis(thiosemicarbazonato) complexes.
Carroll L; Bejot R; Hueting R; King R; Bonnitcha P; Bayly S; Christlieb M; Dilworth JR; Gee AD; Declerck J; Gouverneur V
Chem Commun (Camb); 2010 Jun; 46(23):4052-4. PubMed ID: 20407674
[TBL] [Abstract][Full Text] [Related]
15. Rapid Imaging of Tumor Cell Death In Vivo Using the C2A Domain of Synaptotagmin-I.
Neves AA; Xie B; Fawcett S; Alam IS; Witney TH; de Backer MM; Summers J; Hughes W; McGuire S; Soloviev D; Miller J; Howat WJ; Hu DE; Rodrigues TB; Lewis DY; Brindle KM
J Nucl Med; 2017 Jun; 58(6):881-887. PubMed ID: 28209913
[TBL] [Abstract][Full Text] [Related]
16. Preparation of [61Cu]-2-acetylpyridine thiosemicarbazone complex as a possible PET tracer for malignancies.
Jalilian AR; Rowshanfarzad P; Sabet M; Shafiee A
Appl Radiat Isot; 2006 Mar; 64(3):337-41. PubMed ID: 16293418
[TBL] [Abstract][Full Text] [Related]
17. Copper complexes with dissymmetrically substituted bis(thiosemicarbazone) ligands as a basis for PET radiopharmaceuticals: control of redox potential and lipophilicity.
Brown OC; Baguña Torres J; Holt KB; Blower PJ; Went MJ
Dalton Trans; 2017 Oct; 46(42):14612-14630. PubMed ID: 28703233
[TBL] [Abstract][Full Text] [Related]
18. Copper radionuclides and radiopharmaceuticals in nuclear medicine.
Blower PJ; Lewis JS; Zweit J
Nucl Med Biol; 1996 Nov; 23(8):957-80. PubMed ID: 9004284
[TBL] [Abstract][Full Text] [Related]
19. Differential but convergent functions of Ca2+ binding to synaptotagmin-1 C2 domains mediate neurotransmitter release.
Shin OH; Xu J; Rizo J; Südhof TC
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16469-74. PubMed ID: 19805322
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
